Bangalore Medical College, Bangalore.
J Assoc Physicians India. 2022 Apr;70(4):11-12.
COVID-19 is a global pandemic which has infected more than 100 million individuals and having taken a big toll on the world in terms of morbidity and mortality. The disease may progress in some patients from an influenza like illness to sever acute respiratory illness. Diagnosis of COVID 19 by RTPCR supported by radiological evidence, Material: In this prospective observational study, 60 COVID- 19 positive patients and 60 COVID negative/ suspect patients respectively were enrolled from march 2020 to July 2020 in Bowring and lady Curzon Hospital, Bangalore and they were assessed for taste and smell sensations based on SQOD- NS and questions based on smell and taste component of NHNE survey, symptomatic patients were followed up and duration needed for recovery of symptoms was analysed for P value, chi-square value, other relevant blood and radiological investigations were done. Observation: 1. To compare the olfactory and gustatory dysfunctions in COVID suspects and patients with laboratory-confirmed COVID-19 infection. 2. To assess utility of hypoguesia and hyposmia as discriminant clinical features that might be used for the diagnosis of COVID-19 in patients with ILI. Conclusion: We concluded that patients with COVID 19 positive status had severe spectrum of olfactory dysfunction like anosmia, hyposmia and they will have long recovery time compared to COVID negative /suspect patients .Taste perception was more impaired in COVID positive patients compared to COVID negative /suspects.Covid positive patients had higher sQOD-NS score compared to COVID negative patients and significant associations are seen.
新型冠状病毒肺炎(COVID-19)是一种全球性大流行疾病,已感染超过 1 亿人,在发病率和死亡率方面给世界带来了巨大损失。在一些患者中,这种疾病可能从类似流感的疾病进展为严重的急性呼吸道疾病。RT-PCR 结合影像学证据可诊断 COVID-19。材料:在这项前瞻性观察研究中,我们于 2020 年 3 月至 2020 年 7 月分别从班加罗尔的 Bowring 和 Lady Curzon 医院招募了 60 名 COVID-19 阳性患者和 60 名 COVID 阴性/疑似患者,根据 SQOD-NS 评估他们的味觉和嗅觉感知,并根据 NHNE 调查的嗅觉和味觉成分提出问题。对有症状的患者进行随访,并分析症状恢复所需的时间以进行 P 值、卡方值分析,同时进行其他相关的血液和影像学检查。观察:1. 比较 COVID 疑似患者和实验室确诊 COVID-19 感染患者的嗅觉和味觉障碍。2. 评估味觉减退和嗅觉减退作为鉴别临床特征的效用,这些特征可能用于有 ILI 的 COVID-19 患者的诊断。结论:我们得出结论,COVID-19 阳性患者的嗅觉功能障碍严重,表现为嗅觉丧失、嗅觉减退,与 COVID 阴性/疑似患者相比,他们的恢复时间较长。与 COVID 阴性/疑似患者相比,COVID 阳性患者的味觉感知障碍更严重。COVID 阳性患者的 sQOD-NS 评分高于 COVID 阴性患者,且存在显著相关性。